Cargando…
Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a highly pathogenic respiratory virus with mechanisms that may be driven by innate immune responses. Despite the effort of scientific studies related to this virus, Middle East Respiratory Syndrome (MERS) is still a public health concern. ME...
Autores principales: | Mustafa, Sabeena, Balkhy, Hanan, Gabere, Musa N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Production and hosting by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102797/ https://www.ncbi.nlm.nih.gov/pubmed/28864360 http://dx.doi.org/10.1016/j.jiph.2017.08.009 |
Ejemplares similares
-
Peptide-Protein Interaction Studies of Antimicrobial Peptides Targeting Middle East Respiratory Syndrome Coronavirus Spike Protein: An In Silico Approach
por: Mustafa, Sabeena, et al.
Publicado: (2019) -
The search for therapeutic options for Middle East Respiratory Syndrome (MERS)
por: Arabi, Yaseen M., et al.
Publicado: (2016) -
Preventing healthcare-associated transmission of the Middle East Respiratory Syndrome (MERS): Our Achilles heel
por: Balkhy, Hanan H., et al.
Publicado: (2016) -
Proceedings of the Middle East Respiratory Syndrome (MERS) Coronavirus research initiative workshop, September 9–10 2015 in Riyadh, KSA
por: Arabi, Yaseen M., et al.
Publicado: (2016) -
Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update
por: Aly, Mahmoud, et al.
Publicado: (2017)